Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 11
2003 12
2004 10
2005 6
2006 9
2007 6
2008 10
2009 15
2010 19
2011 26
2012 19
2013 13
2014 13
2015 20
2016 13
2017 25
2018 19
2019 24
2020 19
2021 23
2022 13
Text availability
Article attribute
Article type
Publication date

Search Results

290 results
Results by year
Filters applied: . Clear all
Page 1
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385 Clinical Trial.
Clinical pharmacology of intravitreal anti-VEGF drugs.
Fogli S, Del Re M, Rofi E, Posarelli C, Figus M, Danesi R. Fogli S, et al. Among authors: danesi r. Eye (Lond). 2018 Jun;32(6):1010-1020. doi: 10.1038/s41433-018-0021-7. Epub 2018 Feb 5. Eye (Lond). 2018. PMID: 29398697 Free PMC article. Review.
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial.
Cremolini C, Rossini D, Dell'Aquila E, Lonardi S, Conca E, Del Re M, Busico A, Pietrantonio F, Danesi R, Aprile G, Tamburini E, Barone C, Masi G, Pantano F, Pucci F, Corsi DC, Pella N, Bergamo F, Rofi E, Barbara C, Falcone A, Santini D. Cremolini C, et al. Among authors: danesi r. JAMA Oncol. 2019 Mar 1;5(3):343-350. doi: 10.1001/jamaoncol.2018.5080. JAMA Oncol. 2019. PMID: 30476968 Free PMC article. Clinical Trial.
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.
Del Re M, Cucchiara F, Rofi E, Fontanelli L, Petrini I, Gri N, Pasquini G, Rizzo M, Gabelloni M, Belluomini L, Crucitta S, Ciampi R, Frassoldati A, Neri E, Porta C, Danesi R. Del Re M, et al. Among authors: danesi r. Cancer Immunol Immunother. 2021 Jun;70(6):1667-1678. doi: 10.1007/s00262-020-02810-6. Epub 2020 Dec 14. Cancer Immunol Immunother. 2021. PMID: 33315149 Free PMC article.
Should CYP2D6 be genotyped when treating with tamoxifen?
Del Re M, Rofi E, Citi V, Fidilio L, Danesi R. Del Re M, et al. Among authors: danesi r. Pharmacogenomics. 2017 Jun;18(8):755-756. doi: 10.2217/pgs-2017-0065. Epub 2017 Jun 8. Pharmacogenomics. 2017. PMID: 28593824
Periorbital necrotising fasciitis.
Lazzeri D, Lazzeri S, Figus M, Tascini C, Bocci G, Colizzi L, Giannotti G, Lorenzetti F, Gandini D, Danesi R, Menichetti F, Del Tacca M, Nardi M, Pantaloni M. Lazzeri D, et al. Among authors: danesi r. Br J Ophthalmol. 2010 Dec;94(12):1577-85. doi: 10.1136/bjo.2009.167486. Epub 2009 Nov 5. Br J Ophthalmol. 2010. PMID: 19897473 Review.
Understanding EGFR heterogeneity in lung cancer.
Passaro A, Malapelle U, Del Re M, Attili I, Russo A, Guerini-Rocco E, Fumagalli C, Pisapia P, Pepe F, De Luca C, Cucchiara F, Troncone G, Danesi R, Spaggiari L, De Marinis F, Rolfo C. Passaro A, et al. Among authors: danesi r. ESMO Open. 2020 Oct;5(5):e000919. doi: 10.1136/esmoopen-2020-000919. ESMO Open. 2020. PMID: 33067323 Free PMC article. Review.
290 results